Naturally Lignan-Rich Foods: a Dietary Tool for Health Promotion?

Total Page:16

File Type:pdf, Size:1020Kb

Naturally Lignan-Rich Foods: a Dietary Tool for Health Promotion? molecules Review Naturally Lignan-Rich Foods: A Dietary Tool for Health Promotion? Carmen Rodríguez-García 1,2 , Cristina Sánchez-Quesada 1,2,3 , Estefanía Toledo 4,5,6 , Miguel Delgado-Rodríguez 1,2,7 and José J. Gaforio 1,2,3,7,* 1 Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, Campus las Lagunillas s/n, 23071 Jaén, Spain; [email protected] (C.R.-G.); [email protected] (C.S.-Q.); [email protected] (M.D.-R.) 2 Department of Health Sciences, Faculty of Experimental Sciences, University of Jaén, 23071 Jaén, Spain 3 Agri-food Campus of International Excellence (ceiA3), 14071 Córdoba, Spain 4 Department of Preventive Medicine and Public Health, University of Navarra, 31008 Pamplona, Spain; [email protected] 5 CIBER Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029 Madrid, Spain 6 IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain 7 CIBER Epidemiología y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-953-212-002 Academic Editor: David Barker Received: 28 January 2019; Accepted: 4 March 2019; Published: 6 March 2019 Abstract: Dietary guidelines universally advise adherence to plant-based diets. Plant-based foods confer considerable health benefits, partly attributable to their abundant micronutrient (e.g., polyphenol) content. Interest in polyphenols is largely focused on the contribution of their antioxidant activity to the prevention of various disorders, including cardiovascular disease and cancer. Polyphenols are classified into groups, such as stilbenes, flavonoids, phenolic acids, lignans and others. Lignans, which possess a steroid-like chemical structure and are defined as phytoestrogens, are of particular interest to researchers. Traditionally, health benefits attributed to lignans have included a lowered risk of heart disease, menopausal symptoms, osteoporosis and breast cancer. However, the intake of naturally lignan-rich foods varies with the type of diet. Consequently, based on the latest humans’ findings and gathered information on lignan-rich foods collected from Phenol Explorer database this review focuses on the potential health benefits attributable to the consumption of different diets containing naturally lignan-rich foods. Current evidence highlight the bioactive properties of lignans as human health-promoting molecules. Thus, dietary intake of lignan-rich foods could be a useful way to bolster the prevention of chronic illness, such as certain types of cancers and cardiovascular disease. Keywords: lignans; diet; antioxidants; health promotion; chronic diseases 1. Introduction Polyphenol-rich diets are suggested to possess health benefits. Polyphenols are micronutrients found in plants, and include flavonoids, stilbenes, phenolic acids, lignans and others [1]. They are secondary plant metabolites implicated in protection against pathogens and ultraviolet radiation [2]. Given their diverse chemical structures, different polyphenol classes likely possess differing health benefits [3]. It is therefore important to elucidate the specific potential benefits of each polyphenolic compound. Significant interest has been elicited by lignans, due to their steroid-analogous chemical structure. Accordingly, they are considered to be phytoestrogens. Lignans are bioactive compounds exhibiting various biological properties, including anti-inflammatory, antioxidant and antitumor Molecules 2019, 24, 917; doi:10.3390/molecules24050917 www.mdpi.com/journal/molecules Molecules 2019, 24, 917 2 of 25 activitiesMolecules 2019 [4]., 24 Additionally,, x some epidemiological studies have proposed that lignans decrease2 theof 24 risk of cardiovascular disease, but their effects on other chronic diseases (e.g., breast cancer) remain 46 controversialrisk of cardiovascular [5]. disease, but their effects on other chronic diseases (e.g., breast cancer) remain 47 controversialLignans are [5]. found in relatively low concentrations in various seeds, grains, fruits and vegetables, 48 and inLignans higher concentrations are found in relatively in sesame low and concentrations flax seeds [6]. in Therefore, various seeds, the level grains, of lignan fruits ingestion—and, and vegetables, 49 thus,and in lignan higher bioavailability, concentrations depends in sesame on theand type flax ofseeds diet [6]. consumed Therefore, [7, 8the] and level can of be lignan highly ingestion— variable. 50 Theand, present thus, lignan review bioavailability, attempts to describe depends the on potential the type beneficial of diet consumed effects of lignan [7,8] and intake can on be human highly 51 chronicvariable. disease, The present depending review on attempts the dietary to source.describe the potential beneficial effects of lignan intake on 52 human chronic disease, depending on the dietary source. 2. Biosynthesis, Classification and Presence of Lignans in Foods 53 2. Biosynthesis, Classification and Presence of Lignans in Foods Lignans are a type of secondary plant metabolite exhibiting diverse structures [9]. Plants derive a 54 complexLignans array are of secondary a type of secondary metabolites plant from metabolite only a handful exhibiting of relatively diverse simple structures propenyl [9]. phenolsPlants derive [10]. 55 Biosynthesisa complex array of lignans of secondary is characterized metabolites by afrom remarkable only a handful increase of in relatively molecular simple complexity propenyl [10]. phenols 56 [10].Lignans Biosynthesis share of common lignans biosynthetic is characterized pathways, by a remarkable consist of two increase propyl-benzene in molecular units complexity coupled by[10]. a 57 β,β0-bondLignans [11], share and thuscommon belong biosynthetic to the group pathways, of diphenolic consist compounds of two propyl-benzene [12]. units coupled by 58 a β,β′Lignans-bond [11], may and be organizedthus belong into to eightthe group structural of diphenolic subgroups compounds (according [12]. to the manner in which 59 oxygenLignans is incorporated may be organized and the pattern into eight of cyclization): structural subgroups Dibenzylbutyrolactol, (according dibenzocyclooctadiene,to the manner in which 60 dibenzylbutyrolactone,oxygen is incorporated dibenzylbutane, and the pattern arylnaphthalene,of cyclization): Dibenzylbutyrolactol, aryltetralin, furan and dibenzocyclooctadiene, furofuran (Figure1). 61 Eachdibenzylbutyrolactone, subgroup can be further dibenzylbu subdividedtane, accordingarylnaphthalene, to lignan aryltetralin, molecule oxidation furan and level furofuran and identities (Figure 62 of1). non-propyl Each subgroup aromatic can rings be further present subdivided on side chains according [13,14]. to lignan molecule oxidation level and 63 identities of non-propyl aromatic rings present on side chains [13,14]. dibenzylbutirolactol dibe nzocyclooctadiene dibenzylbutirolactone dibenzylbutane arylnapththalene arylte tralin furan furofuran 64 65 FigureFigure 1. 1.Structural Structural subgroups subgroups of of lignans lignans (Ar=Aryl). (Ar=Aryl). 66 OfOf the the eight eight lignan lignan subclasses, subclasses, synthesis synthesis of furofurans—which of furofurans—which exhibit a 2,6-diaryl-3,7- exhibit a 67 2,6-diaryl-3,7-dioxabicyclooctanedioxabicyclooctane skeleton—is initiated skeleton—is by the initiated enantioselective by the enantioselectivedimerization of dimerizationtwo coniferyl 68 ofalcohol two coniferyl units derived alcohol from units the shikimate derived from biosynthetic the shikimate pathway biosynthetic (Figure 2) [14]. pathway To date, (Figure 53 species2)[ 14 ].of 69 Tofurofuran date, 53 specieslignans of have furofuran been reported lignans have in 41 been genera reported of 27 in plant 41 genera families, of 27 including plant families, Thymelaeaceae, including 70 Thymelaeaceae,Styracaceae, Scrophulariaceae, Styracaceae, Scrophulariaceae, Saururaceae, Rutaceae, Saururaceae, Rhizophoraceae, Rutaceae, Rhizophoraceae, Piperaceae, Pedaliaceae, Piperaceae, 71 Pedaliaceae,Orobanchaceae, Orobanchaceae, Myristicaceae, Myristicaceae, Magnoliaceae, Magnoliaceae, Lauraceae, Lamiaceae, Lauraceae, Geraniaceae, Lamiaceae, Dioscoreaceae, Geraniaceae, 72 Dioscoreaceae,Cyperaceae, Cupressaceae, Cyperaceae, Cupressaceae, Compositae, Compositae,Combretaceae, Combretaceae, Cactaceae, Cactaceae,Aristolochiaceae, Aristolochiaceae, Arecaceae, 73 Arecaceae,Araliaceae, Araliaceae, Aquifoliaceae, Aquifoliaceae, Apocynaceae, Apocynaceae, Acoraceae Acoraceaeand Acanthaceae. and Acanthaceae. Furofuran Furofuranlignans are lignans present 74 arein the present bark, in bulbs, the bark, leaves, bulbs, seeds, leaves, stems seeds, and stemsroots of and these roots plants of these [14]. plants [14]. 75 However,However, depending depending onon thethe enzymeenzyme that catalyzescatalyzes modification modification of of the the precursor precursor metabolite, metabolite, a 76 avariety variety of of lignans lignans can be synthesizedsynthesized (Figure(Figure2 ).2). TheThe major major lignans—which lignans—which possess possess numerous numerous 77 pharmacologicalpharmacological properties—areproperties—are artigenin,artigenin, enterodiol,enterodiol, enterolactone,enterolactone, sesamin,sesamin, syringaresinol,syringaresinol, 78 medioresinol,medioresinol, ( (−−)-matairesinol,)-matairesinol, (−)-secoisolariciresinol, (−)-secoisolariciresinol, (+)-laricire (+)-lariciresinolsinol and (+)-pinoresinol, and (+)-pinoresinol, among 79 amongothers others[15]. [15]. Molecules 2019, 24, 917 3
Recommended publications
  • Ilamycin C Induces Apoptosis and Inhibits Migration and Invasion In
    Xie et al. Journal of Hematology & Oncology (2019) 12:60 https://doi.org/10.1186/s13045-019-0744-3 RESEARCH Open Access Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway Qing Xie1†, Zhijie Yang2†, Xuanmei Huang1, Zikang Zhang1, Jiangbin Li1, Jianhua Ju2*, Hua Zhang1* and Junying Ma2* Abstract Background: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with poor prognosis, and its treatment remains a challenge due to few targeted medicines and high risk of relapse, metastasis, and drug resistance. Thus, more effective drugs and new regimens for the therapy of TNBC are urgently needed. Ilamycins are a kind of cyclic peptides and produced by Streptomyces atratus and Streptomyces islandicus with effective anti-tuberculosis activity. Ilamycin C is a novel compound isolated from the deep South China Sea- derived Streptomyces atratus SCSIO ZH16 and exhibited a strong cytotoxic activity against several cancers including breast cancer cell line MCF7. However, the cytotoxic activity of Ilamycin C to TNBC cells and a detailed antitumor mechanism have not been reported. Methods: CCK-8 assays were used to examine cell viability and cytotoxic activity of Ilamycin C to TNBC, non-TNBC MCF7, and nonmalignant MCF10A cells. EdU assays and flow cytometry were performed to assess cell proliferation and cell apoptosis. Transwell migration and Matrigel invasion assays were utilized to assess the migratory and invading capacity of TNBC cells following the treatment of Ilamycin C. The expressions of proteins were detected by western blot. Results: In this study, we found that Ilamycin C has more preferential cytotoxicity in TNBC cells than non-TNBC MCF7 and nonmalignant MCF10A cells.
    [Show full text]
  • Thromboxane A2 Receptor Antagonist SQ29548 Attenuates SH‑SY5Y Neuroblastoma Cell Impairments Induced by Oxidative Stress
    INTERNATIONAL JOURNAL OF MOleCular meDICine 42: 479-488, 2018 Thromboxane A2 receptor antagonist SQ29548 attenuates SH‑SY5Y neuroblastoma cell impairments induced by oxidative stress GAOYU CAI1*, AIJUAN YAN2*, NINGZHEN FU3 and YI FU1 1Department of Neurology, Rui Jin Hospital, Shanghai Jiao Tong University, Shanghai 200025; 2Department of Neurology, Xin Hua Hospital, Shanghai Jiao Tong University, Shanghai 200082; 3Department of Pancreatic Surgery, Rui Jin College of Clinical Medicine, Rui Jin Hospital, Shanghai Jiao Tong University, Shanghai 200025, P.R. China Received September 28, 2017; Accepted March 21, 2018 DOI: 10.3892/ijmm.2018.3589 Abstract. Thromboxane A2 receptor (TXA2R) serves a vital SQ29548, an antagonist of TXA2R, improved the antioxidant role in numerous neurological disorders. Our previous study capacities of SH-SY5Y cells and reduced the cell apoptosis indicated that SQ29548, an antagonist of TXA2R, attenuated through the inhibition of MAPK pathways. the induced neuron damage in cerebral infarction animals; however, the underlying mechanism remains unknown. Introduction Certain studies revealed a new role of TXA2R in the regula- tion of oxidative stress, which is one of the basic pathological Thromboxane A2 receptor (TXA2R), a member of the G processes in neurological disorders. Thus, the present study protein-coupled receptor family (1), is broadly distributed attempted to examine whether the inhibition of TXA2R with in platelets (2), as well as epithelial (3), smooth muscle (4), SQ29548 helped to protect the nerve cells against oxidative glial and nerve cells in the brain (5). TXA2R is regarded as a stress. SQ29548 was utilized as a TXA2R antagonist, and traditional coagulation and inflammation‑associated receptor, relevant assays were performed to detect the cell viability, which is also closely associated with neurological disorders.
    [Show full text]
  • Lignan Accumulation in Two-Phase Cultures of Taxus X Media Hairy Roots
    Plant Cell, Tissue and Organ Culture (PCTOC) https://doi.org/10.1007/s11240-018-1390-0 ORIGINAL ARTICLE Lignan accumulation in two-phase cultures of Taxus x media hairy roots K. Sykłowska‑Baranek1 · K. Łysik1 · M. Jeziorek1 · A. Wencel1 · M. Gajcy1 · A. Pietrosiuk1 Received: 3 August 2017 / Accepted: 6 February 2018 © The Author(s) 2018. This article is an open access publication Abstract The biosynthetic potential for six lignans accumulation in two lines of Taxus x media hairy roots was investigated. The cul- tures of KT and ATMA hairy root lines were supplemented with precursors: coniferyl alcohol (CA 1, 10 or 100 µM) and/or L-phenylalanine (100 µM PHEN) and/or methyl jasmonate (100 µM MeJa). Moreover the two-phase in vitro cultures sup- ported with perfluorodecalin (PFD) as a gas carrier and in situ extrahent were used. The hairy root lines differed in lignan production profiles. In the control untreated cultures KT roots did not accumulate secoisolariciresinol and lariciresinol while ATMA roots did not accumulate matairesinol. In ATMA roots the treatment with CA (1 or 10 µM) resulted in the production of lariciresinol and secoisolariciresinol whereas solely lariciresinol was present after 100 µM CA application. Elicitation with 1 µM CA and MeJa yielded with hydroxymatairesinol aglyca and lariciresinol glucosides with their highest content 37.88 and 3.19 µg/g DW, respectively. The stimulatory effect of simultaneous treatment with 1 µM CA, PHEN and MeJa on lignan production was observed when the cultures were supplemented with PFD-aerated or degassed. In ATMA root cultures these applied conditions were the most favourable for matairesinol content which amounted to 199.86 and 160.25 µg/g DW in PFD-aerated and PFD-degassed supported cultures, respectively.
    [Show full text]
  • Pinoresinol Reductase 1 Impacts Lignin Distribution During Secondary Cell Wall Biosynthesis in Arabidopsis
    Phytochemistry xxx (2014) xxx–xxx Contents lists available at ScienceDirect Phytochemistry journal homepage: www.elsevier.com/locate/phytochem Pinoresinol reductase 1 impacts lignin distribution during secondary cell wall biosynthesis in Arabidopsis Qiao Zhao a, Yining Zeng b,e, Yanbin Yin c, Yunqiao Pu d,e, Lisa A. Jackson a,e, Nancy L. Engle e,f, Madhavi Z. Martin e,f, Timothy J. Tschaplinski e,f, Shi-You Ding b,e, Arthur J. Ragauskas d,e, ⇑ Richard A. Dixon a,e,g, a Plant Biology Division, Samuel Roberts Noble Foundation, 2510 Sam Noble Parkway, Ardmore, OK 73401, USA b Biosciences Center, National Renewable Energy Laboratory, Golden, CO 80401, USA c Department of Biological Sciences, Northern Illinois University, DeKalb, IL 60115, USA d Institute of Paper Science and Technology, Georgia Institute of Technology, Atlanta, GA, USA e BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA f Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA g Department of Biological Sciences, University of North Texas, Denton, TX 76203, USA article info abstract Article history: Pinoresinol reductase (PrR) catalyzes the conversion of the lignan (À)-pinoresinol to (À)-lariciresinol in Available online xxxx Arabidopsis thaliana, where it is encoded by two genes, PrR1 and PrR2, that appear to act redundantly. PrR1 is highly expressed in lignified inflorescence stem tissue, whereas PrR2 expression is barely detect- Keywords: able in stems. Co-expression analysis has indicated that PrR1 is co-expressed with many characterized Lignan genes involved in secondary cell wall biosynthesis, whereas PrR2 expression clusters with a different Lignin set of genes.
    [Show full text]
  • Nutraceuticals Brian Lockwood
    CjigVXZji^XVah HZXdcYZY^i^dc 7g^VcAdX`lddY 00 Prelim 2/3/07 18:51 Page i Nutraceuticals 00 Prelim 2/3/07 18:51 Page ii 00 Prelim 2/3/07 18:51 Page iii Nutraceuticals A guide for healthcare professionals Second edition Brian Lockwood BPharm, PhD, MRPharmS Senior Lecturer in Pharmacy, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK London • Chicago 00 Prelim 2/3/07 18:51 Page iv Published by the Pharmaceutical Press An imprint of RPS Publishing 1 Lambeth High Street, London SE1 7JN, UK 100 South Atkinson Road, Suite 200, Grayslake, IL 60030–7820, USA © Pharmaceutical Press 2007 is a trade mark of RPS Publishing RPS Publishing is the publishing organisation of the Royal Pharmaceutical Society of Great Britain First edition published 2002 Second edition published 2007 Typeset by Type Study, Scarborough, North Yorkshire Printed in Great Britain by TJ International, Padstow, Cornwall ISBN 978 0 85369 659 9 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without the prior written permission of the copyright holder. The publisher makes no representation, express or implied, with regard to the accuracy of the information contained in this book and cannot accept any legal responsibility or liability for any errors or omissions that may be made. The right of Brian Lockwood to be identified as the author of this work has been asserted by him in accordance with sections 77 and 78 and subject to section 79(6) of the Copyright, Designs and Patents Act, 1988.
    [Show full text]
  • Serum Enterolactone
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Julkari Annamari Kilkkinen SERUM ENTEROLACTONE D E T E R M I N A N T S A N D A S S O C I A T I O N S W I T H B R E A S T A N D P R O S T A T E C A N C E R S A C A D E M I C D I S S E R T A T I O N To be presented with the permission of the Faculty of Medicine, University of Helsinki, for public examination in Auditorium XII, University Main Building, on June 11th, 2004, at 12 noon. National Public Health Institute, Helsinki, Finland and Department of Public Health, University of Helsinki, Finland Helsinki 2004 P u b l i c a t i o n s o f t h e N a t i o n a l P u b l i c H e a l t h I n s t i t u t e K T L A 1 0 / 2 0 0 4 Copyright National Public Health Institute Julkaisija-Utgivare-Publisher Kansanterveyslaitos (KTL) Mannerheimintie 166 00300 Helsinki Puh. vaihde (09) 474 41, telefax (09) 4744 8408 Folkhälsoinstitutet Mannerheimvägen 166 00300 Helsingfors Tel. växel (09) 474 41, telefax (09) 4744 8408 National Public Health Institute Mannerheimintie 166 FIN-00300 Helsinki, Finland Telephone +358 9 474 41, telefax +358 9 4744 8408 ISBN 951-740-448-4 ISSN 0359-3584 ISBN 951-740-449-2 (pdf) ISSN 1458-6290 (pdf) Hakapaino Oy Helsinki 2004 S u p e r v i s e d b y Professor Pirjo Pietinen Department of Epidemiology and Health Promotion National Public Health Institute, Helsinki, Finland Professor Jarmo Virtamo Department of Epidemiology and Health Promotion National Public Health Institute, Helsinki, Finland R e v i e w e d b y Associate Professor Sari
    [Show full text]
  • Effect of Drying Methods on Volatile Compounds of Burdock (Arctium Lappa L.) Root Tea As Revealed by Gas Chromatography Mass Spectrometry-Based Metabolomics
    foods Article Effect of Drying Methods on Volatile Compounds of Burdock (Arctium lappa L.) Root Tea as Revealed by Gas Chromatography Mass Spectrometry-Based Metabolomics Junjie Xia 1,†, Zili Guo 1,† , Sheng Fang 2 , Jinping Gu 1 and Xianrui Liang 1,* 1 Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China; [email protected] (J.X.); [email protected] (Z.G.); [email protected] (J.G.) 2 School of Food Science and Biotechnology, Zhejiang Gongshang University, Xuezheng Street No. 18, Hangzhou 310018, China; [email protected] * Correspondence: [email protected]; Tel.: +86-571-8832-0420 † These two authors contributed equally to the work. Abstract: Burdock (Arctium lappa L.) is one of the nutritional foods widely planted in many countries. Dried burdock root (BR) is available as a herbal tincture and tea in many Asian countries with good flavor and taste. In this study, the volatile components in dried BR were identified and the effects of different drying methods on the volatile components were investigated by HS-GC-MS method. A total of 49 compounds were identified. Different drying methods including hot-air drying (HD, at 50, ◦ ◦ 60, 70, and 80 C), vacuum drying (VD, at 50, 60, 70, and 80 C), sunlight drying (SD), natural drying (ND), and vacuum freeze drying (VFD) were evaluated by HS-GC-MS-based metabolomics method. Citation: Xia, J.; Guo, Z.; Fang, S.; Results showed that different drying methods produced different effects on the volatile compounds. Gu, J.; Liang, X. Effect of Drying It was observed that 2,3-pentanedione, 1-(1H-pyrrol-2-yl)-ethanone, furfural, and heptanal were Methods on Volatile Compounds of detected at higher concentrations in HD 80 and VD 70.
    [Show full text]
  • FOODINTEGRITY Ensuring the Integrity of the European Food Chain
    FOODINTEGRITY Ensuring the Integrity of the European food chain 613688: Collaborative Project Seventh Framework Programme KBBE.2013.2.4-01: Assuring quality and authenticity in the food chain Deliverable: 14.1 Title: Report on development of chemical and metabolomic markers of product integrity and stability along processing. Author(s): Baroni, María Verónica; Erban, Alexander; Kopka, Joachim; Wunderlin, Daniel Beneficiary(s): Food Integrity Consortia Date of preparation: September 21th 2017. Period covered: November-2016; August-2017 Status: version 1 Dissemination level PU Public X PP Restricted to other participants RE Restricted to a group specified by the consortium CO Confidential, only members of the consortium The project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement No. 613688. Deliverable 14.1, version 1, 21‐09‐2017 Deliverable 14.1 Report on development of chemical and metabolomic markers of product integrity and stability along processing. TABLE OF CONTENTS Page Nr. 1 Description of Deliverable 3 2 Achievement of the Deliverable 3 2.1 Chemical fractionation and profiling of seeds for the discovery of potential chemical markers by GC-MS (MPIMP). 3 2.1.1 Seed selection (EU market). 3 2.1.2 Fractionation scheme to evaluate chemical markers in seeds 4 2.1.3 Evaluation of chemical markers in seeds by GC-MS and chemometrics 5 2.2 Chemical fractionation and profiling of seeds, and bakery products containing seeds, for the discovery of potential chemical markers by LC-MS (CONICET-ICYTAC). 10 2.2.1 Seed sampling, extraction and analytical procedures (AR mark et).
    [Show full text]
  • Supplementary Information
    Supplementary Information Network-based Drug Repurposing for Novel Coronavirus 2019-nCoV Yadi Zhou1,#, Yuan Hou1,#, Jiayu Shen1, Yin Huang1, William Martin1, Feixiong Cheng1-3,* 1Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA 2Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA 3Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA #Equal contribution *Correspondence to: Feixiong Cheng, PhD Lerner Research Institute Cleveland Clinic Tel: +1-216-444-7654; Fax: +1-216-636-0009 Email: [email protected] Supplementary Table S1. Genome information of 15 coronaviruses used for phylogenetic analyses. Supplementary Table S2. Protein sequence identities across 5 protein regions in 15 coronaviruses. Supplementary Table S3. HCoV-associated host proteins with references. Supplementary Table S4. Repurposable drugs predicted by network-based approaches. Supplementary Table S5. Network proximity results for 2,938 drugs against pan-human coronavirus (CoV) and individual CoVs. Supplementary Table S6. Network-predicted drug combinations for all the drug pairs from the top 16 high-confidence repurposable drugs. 1 Supplementary Table S1. Genome information of 15 coronaviruses used for phylogenetic analyses. GenBank ID Coronavirus Identity % Host Location discovered MN908947 2019-nCoV[Wuhan-Hu-1] 100 Human China MN938384 2019-nCoV[HKU-SZ-002a] 99.99 Human China MN975262
    [Show full text]
  • Plant Phenolics: Bioavailability As a Key Determinant of Their Potential Health-Promoting Applications
    antioxidants Review Plant Phenolics: Bioavailability as a Key Determinant of Their Potential Health-Promoting Applications Patricia Cosme , Ana B. Rodríguez, Javier Espino * and María Garrido * Neuroimmunophysiology and Chrononutrition Research Group, Department of Physiology, Faculty of Science, University of Extremadura, 06006 Badajoz, Spain; [email protected] (P.C.); [email protected] (A.B.R.) * Correspondence: [email protected] (J.E.); [email protected] (M.G.); Tel.: +34-92-428-9796 (J.E. & M.G.) Received: 22 October 2020; Accepted: 7 December 2020; Published: 12 December 2020 Abstract: Phenolic compounds are secondary metabolites widely spread throughout the plant kingdom that can be categorized as flavonoids and non-flavonoids. Interest in phenolic compounds has dramatically increased during the last decade due to their biological effects and promising therapeutic applications. In this review, we discuss the importance of phenolic compounds’ bioavailability to accomplish their physiological functions, and highlight main factors affecting such parameter throughout metabolism of phenolics, from absorption to excretion. Besides, we give an updated overview of the health benefits of phenolic compounds, which are mainly linked to both their direct (e.g., free-radical scavenging ability) and indirect (e.g., by stimulating activity of antioxidant enzymes) antioxidant properties. Such antioxidant actions reportedly help them to prevent chronic and oxidative stress-related disorders such as cancer, cardiovascular and neurodegenerative diseases, among others. Last, we comment on development of cutting-edge delivery systems intended to improve bioavailability and enhance stability of phenolic compounds in the human body. Keywords: antioxidant activity; bioavailability; flavonoids; health benefits; phenolic compounds 1. Introduction Phenolic compounds are secondary metabolites widely spread throughout the plant kingdom with around 8000 different phenolic structures [1].
    [Show full text]
  • Phase I and Ii Enzyme Induction and Inhibition by Secoisolariciresinol Diglucoside and Its Aglycone
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of Saskatchewan's Research Archive PHASE I AND II ENZYME INDUCTION AND INHIBITION BY SECOISOLARICIRESINOL DIGLUCOSIDE AND ITS AGLYCONE A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the Requirements for the Degree of Master of Science in the Toxicology Graduate Program University of Saskatchewan Saskatoon, Saskatchewan Canada Erin Margaret Rose Boyd ©Copyright Erin Margaret Rose Boyd, April 2007, All rights reserved. PERMISSION TO USE In presenting this thesis in partial fulfillment of the requirements for a Postgraduate degree from the University of Saskatchewan, I agree that the Libraries of this University may make it freely available for inspection. I further agree that permission for copying of this thesis in any manner, in whole or in part, for scholarly purposes may be granted by the professor or professors who supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the College in which my thesis work was done. It is also understood that any copying or publication or use of this thesis or parts thereof for financial gain shall not be allowed without my written permission. It is also understood that due recognition shall be given to me and to the University of Saskatchewan in any scholarly use which may be made of any material in my thesis. Requests for permission to copy or to make other use of material in this thesis in whole or part should be addressed to: Chair of the Toxicology Graduate Program Toxicology Centre University of Saskatchewan 44 Campus Drive Saskatoon, SK, Canada, S7N 5B3 i ABSTRACT The flaxseed lignan, secoisolariciresinol diglucoside (SDG), and its aglycone, secoisolariciresinol (SECO), have demonstrated benefits in the treatment and/or prevention of cancer, diabetes and cardiovascular disease.
    [Show full text]
  • Supplementary Materials Evodiamine Inhibits Both Stem Cell and Non-Stem
    Supplementary materials Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70 Seung Yeob Hyun, Huong Thuy Le, Hye-Young Min, Honglan Pei, Yijae Lim, Injae Song, Yen T. K. Nguyen, Suckchang Hong, Byung Woo Han, Ho-Young Lee - 1 - Table S1. Short tandem repeat (STR) DNA profiles for human cancer cell lines used in this study. MDA-MB-231 Marker H1299 H460 A549 HCT116 (MDA231) Amelogenin XX XY XY XX XX D8S1179 10, 13 12 13, 14 10, 14, 15 13 D21S11 32.2 30 29 29, 30 30, 33.2 D7S820 10 9, 12 8, 11 11, 12 8 CSF1PO 12 11, 12 10, 12 7, 10 12, 13 D3S1358 17 15, 18 16 12, 16, 17 16 TH01 6, 9.3 9.3 8, 9.3 8, 9 7, 9.3 D13S317 12 13 11 10, 12 13 D16S539 12, 13 9 11, 12 11, 13 12 D2S1338 23, 24 17, 25 24 16 21 D19S433 14 14 13 11, 12 11, 14 vWA 16, 18 17 14 17, 22 15 TPOX 8 8 8, 11 8, 9 8, 9 D18S51 16 13, 15 14, 17 15, 17 11, 16 D5S818 11 9, 10 11 10, 11 12 FGA 20 21, 23 23 18, 23 22, 23 - 2 - Table S2. Antibodies used in this study. Catalogue Target Vendor Clone Dilution ratio Application1) Number 1:1000 (WB) ADI-SPA- 1:50 (IHC) HSP70 Enzo C92F3A-5 WB, IHC, IF, IP 810-F 1:50 (IF) 1 :1000 (IP) ADI-SPA- HSP90 Enzo 9D2 1:1000 WB 840-F 1:1000 (WB) Oct4 Abcam ab19857 WB, IF 1:100 (IF) Nanog Cell Signaling 4903S D73G4 1:1000 WB Sox2 Abcam ab97959 1:1000 WB ADI-SRA- Hop Enzo DS14F5 1:1000 WB 1500-F HIF-1α BD 610958 54/HIF-1α 1:1000 WB pAkt (S473) Cell Signaling 4060S D9E 1:1000 WB Akt Cell Signaling 9272S 1:1000 WB pMEK Cell Signaling 9121S 1:1000 WB (S217/221) MEK Cell Signaling 9122S 1:1000
    [Show full text]